Background and Aim: Eosinophilic esophagitis is an inflammatory disorder of the esophagus that is being increasingly diagnosed in the adult population. The present study aimed to determine the prevalence of eosinophilic esophagitis among Egyptian patients presenting with refractory GERD symptoms. Methods: 40 consecutive adult Egyptian patients with refractory GERD symptoms were enrolled in the study. Upper GIT endoscopy was done for all participants with at least 3 biopsies taken from 2 different sites in the esophagus including the distal and either mid or proximal esophagus even if the esophagus appeared endoscopically normal. Gastric and duodenal biopsies were also taken along with esophageal biopsies. All biopsies were examined histopathologically by blinded gastrointestinal pathologists. An esophageal eosinophilic count > 15/HPF, along with normal gastric and duodenal biopsies, substantiated the diagnosis of eosinophilic esophagitis. Results: The prevalence of eosinophilic esophagitis in this cohort was 2.5% (1/40). The affected participant was a 27 year old female patient who had a history of bronchial asthma (type 1 hypersensitivity reaction) for which she was treated with ,on demand, inhaled bronchodilators (short acting β agonist). The endoscopic examination of the affected participant showed furrows and plaques which are strongly suggestive of eosinophilic esophagitis. Conclusion: the low prevalence rate of eosinophilic esophagitis among the current small cohort of Egyptian patients with refractory GERD symptoms strongly mandates the search for additional data concerning the indications for esophageal biopsy in this subset of patients. History of atopy may warrant suspicion of eosinophilic esophagitis in this subset of patients.
| Published in | American Journal of Internal Medicine (Volume 2, Issue 2) |
| DOI | 10.11648/j.ajim.20140202.12 |
| Page(s) | 15-19 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2014. Published by Science Publishing Group |
Eosinophilic, Esophagitis, Refractory, GERD
| [1] | Rothenberg ME. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol, 2004 Jan; 113(1):11-28 |
| [2] | Potter JW, Saeian K, Staff D, Massey BT, Komorowski RA, Shaker R, Hogan WJ. Eosinophilic esophagitis in adults: an emerging problem with unique esophageal features. Gastrointest Endosc. 2004 Mar; 59(3):355-61. |
| [3] | Fox VL, Nurko S, Furuta GT. Eosinophilic esophagitis: It’s not just kid’s stuff. Gastrointestinal Endos 2002; 56:260-270. |
| [4] | Desai TK, Stecevic V, Chang CH, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61:795–801. |
| [5] | Markowitz JE, Liacouras CA. Eosinophilic esophagitis. Gastroenterol Clin North Am. 2003; 13(3):949–966. |
| [6] | Anil Mishra, Simon P. Hogan, Eric B. Brandt, and Marc E. Rothenberg. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest.2001; 107(1): 83–90. |
| [7] | Morrow JB, Vargo JJ, Goldblum JR, Richter JE. The ringed esophagus (histological features of GERD). Am J Gastroenterol. 2001;96:984–989 |
| [8] | Ngo P, Furuta GT, Antonioli DA, Fox VL. Eosinophils in the esophagus: peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol 2006; 101:1666–1670. |
| [9] | Rothenberg ME, Mishra A, Collins MH, Putnam PE. Pathogenesis and clinical features of eosinophilic esophagitis. J Allergy Clin Immunol 2001;108:891–894. |
| [10] | Arora AS, Yamazaki K. Eosinophilic esophagitis: asthma of the esophagus? Clin Gastroenterol Hepatol 2004;2:523–530. |
| [11] | Furuta GT, Liacouras CA, Collins MH, Gupta SK, Justinich C, Putnam PE, et al . Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007;133:1342–1363. |
| [12] | Ganesh R. Veerappan, Joseph L. Perry, Timothy J. Duncan, Thomas P. Baker, Corinne Maydonovitch, Jason M. Lake, et al . Prevalence of Eosinophilic Esophagitis in an Adult Population Undergoing Upper Endoscopy: A Prospective Study. Clinical gastroenterology and hepatology 2009;7:420–426 |
| [13] | Joel E Richter. How to manage refractory GERD. Nature clinical practice Gastroenterology & Hepatology; 2007; (12):658:664. |
| [14] | Collins MH. Histopathologic features of eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008;18:59–71. |
| [15] | Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a metaanalysis. Gastroenterology. 1997;112:1798-810. |
| [16] | Malfertheiner P, Fass R, Quigley EM, Modlin IM, Malagelada JR, Moss SF, et al. Review article: from gastrin to gastro-oesophageal reflux disease – a century of acid suppression. Aliment Pharmacol Ther. 2006;23:683-90. |
| [17] | Fass R, Shapiro R, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease-where next? Aliment Pharmacol Ther. 2005; 22:79-94. |
| [18] | Cla´udia Cristina de Sa´, Humberto Setsuo Kishi, Ana Luiza Silva-Werneck, Joaquim Prado Pinto de Moraes–Filho, Jaime Natan Eisig, Ricardo Correa Barbuti, et al. Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor.. CLINICS 2011; 66(4):557-561. |
| [19] | Foroutan M, Norouzi A, Molaei M, Mirbagheri SA, Irvani S, Sadeghi A, et al. Eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease. Dig Dis Sci. 2010; 55:28-31. |
| [20] | Poh CH, Gasiorowska A, Navarro-Rodriguez T, Willis MR, Hargadon D, Noelck N,et al. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc 2010;71:28–34. |
| [21] | Garcia-Compean D, Gonzalez Gonzalez JA, Marrufo Garcia CA, Flores Gutierrez JP, Barboza Quintana O, Galindo Rodriguez G, et al. Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: A prospective study. Dig Liver Dis. 2011; 43(3):204-8. |
| [22] | IKUO HIRANO. Eosinophilic Esophagitis and Gastroesophageal Reflux Disease: There and Back Again. Clinical gastroenterology and hepatology 2011; 9(2):99-101 |
| [23] | Kottyan LC, Collier AR, Cao KH, Niese KA, Hedgebeth M, Radu CG, et al. Eosinophil viability is increased by acidic pH in a cAMP- and GPR65-dependent manner. Blood 2009; 114:2774–2782. |
| [24] | Paterson WG. Role of mast cell-derived mediators in acid-induced shortening of the esophagus. Am J Physiol 1998; 274(Pt 1): G385–G388. |
| [25] | Zhang X, Cheng E, Huo X, Yu C, Kathy K. Hormi-Carver, Andersen J , et al. In esophageal squamous epithelial cell lines from patients with eosinophilic esophagitis (EoE), omeprazole blocks the stimulated secretion of eotaxin-3: a potential anti-inflammatory effect of omeprazole in EoE that is independent of acid inhibition. Gastroenterology 2010;138:S-122. |
| [26] | Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol. 2007;102:1301–6. |
| [27] | Nonevski I, Downs E, Falk G. Eosinophilic esophagitis: an increasingly recognized cause of dysphagia, food impaction, and refractory heartburn. Cleve Clin J Med. 2008;75:623---6, 629-33. |
| [28] | Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Immunol 2003; 112:796–797. |
APA Style
Mohamed El malatawy, Hanan Badawy, Nanees Adel, Behnam Tahmasebpour, Reham Al Swaff. (2014). Prevalence of Eosinophilic Esophagitis in Patients with Refractory Gastro-esophageal Reflux Disease Symptoms. American Journal of Internal Medicine, 2(2), 15-19. https://doi.org/10.11648/j.ajim.20140202.12
ACS Style
Mohamed El malatawy; Hanan Badawy; Nanees Adel; Behnam Tahmasebpour; Reham Al Swaff. Prevalence of Eosinophilic Esophagitis in Patients with Refractory Gastro-esophageal Reflux Disease Symptoms. Am. J. Intern. Med. 2014, 2(2), 15-19. doi: 10.11648/j.ajim.20140202.12
AMA Style
Mohamed El malatawy, Hanan Badawy, Nanees Adel, Behnam Tahmasebpour, Reham Al Swaff. Prevalence of Eosinophilic Esophagitis in Patients with Refractory Gastro-esophageal Reflux Disease Symptoms. Am J Intern Med. 2014;2(2):15-19. doi: 10.11648/j.ajim.20140202.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajim.20140202.12,
author = {Mohamed El malatawy and Hanan Badawy and Nanees Adel and Behnam Tahmasebpour and Reham Al Swaff},
title = {Prevalence of Eosinophilic Esophagitis in Patients with Refractory Gastro-esophageal Reflux Disease Symptoms},
journal = {American Journal of Internal Medicine},
volume = {2},
number = {2},
pages = {15-19},
doi = {10.11648/j.ajim.20140202.12},
url = {https://doi.org/10.11648/j.ajim.20140202.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20140202.12},
abstract = {Background and Aim: Eosinophilic esophagitis is an inflammatory disorder of the esophagus that is being increasingly diagnosed in the adult population. The present study aimed to determine the prevalence of eosinophilic esophagitis among Egyptian patients presenting with refractory GERD symptoms. Methods: 40 consecutive adult Egyptian patients with refractory GERD symptoms were enrolled in the study. Upper GIT endoscopy was done for all participants with at least 3 biopsies taken from 2 different sites in the esophagus including the distal and either mid or proximal esophagus even if the esophagus appeared endoscopically normal. Gastric and duodenal biopsies were also taken along with esophageal biopsies. All biopsies were examined histopathologically by blinded gastrointestinal pathologists. An esophageal eosinophilic count > 15/HPF, along with normal gastric and duodenal biopsies, substantiated the diagnosis of eosinophilic esophagitis. Results: The prevalence of eosinophilic esophagitis in this cohort was 2.5% (1/40). The affected participant was a 27 year old female patient who had a history of bronchial asthma (type 1 hypersensitivity reaction) for which she was treated with ,on demand, inhaled bronchodilators (short acting β agonist). The endoscopic examination of the affected participant showed furrows and plaques which are strongly suggestive of eosinophilic esophagitis. Conclusion: the low prevalence rate of eosinophilic esophagitis among the current small cohort of Egyptian patients with refractory GERD symptoms strongly mandates the search for additional data concerning the indications for esophageal biopsy in this subset of patients. History of atopy may warrant suspicion of eosinophilic esophagitis in this subset of patients.},
year = {2014}
}
TY - JOUR T1 - Prevalence of Eosinophilic Esophagitis in Patients with Refractory Gastro-esophageal Reflux Disease Symptoms AU - Mohamed El malatawy AU - Hanan Badawy AU - Nanees Adel AU - Behnam Tahmasebpour AU - Reham Al Swaff Y1 - 2014/03/10 PY - 2014 N1 - https://doi.org/10.11648/j.ajim.20140202.12 DO - 10.11648/j.ajim.20140202.12 T2 - American Journal of Internal Medicine JF - American Journal of Internal Medicine JO - American Journal of Internal Medicine SP - 15 EP - 19 PB - Science Publishing Group SN - 2330-4324 UR - https://doi.org/10.11648/j.ajim.20140202.12 AB - Background and Aim: Eosinophilic esophagitis is an inflammatory disorder of the esophagus that is being increasingly diagnosed in the adult population. The present study aimed to determine the prevalence of eosinophilic esophagitis among Egyptian patients presenting with refractory GERD symptoms. Methods: 40 consecutive adult Egyptian patients with refractory GERD symptoms were enrolled in the study. Upper GIT endoscopy was done for all participants with at least 3 biopsies taken from 2 different sites in the esophagus including the distal and either mid or proximal esophagus even if the esophagus appeared endoscopically normal. Gastric and duodenal biopsies were also taken along with esophageal biopsies. All biopsies were examined histopathologically by blinded gastrointestinal pathologists. An esophageal eosinophilic count > 15/HPF, along with normal gastric and duodenal biopsies, substantiated the diagnosis of eosinophilic esophagitis. Results: The prevalence of eosinophilic esophagitis in this cohort was 2.5% (1/40). The affected participant was a 27 year old female patient who had a history of bronchial asthma (type 1 hypersensitivity reaction) for which she was treated with ,on demand, inhaled bronchodilators (short acting β agonist). The endoscopic examination of the affected participant showed furrows and plaques which are strongly suggestive of eosinophilic esophagitis. Conclusion: the low prevalence rate of eosinophilic esophagitis among the current small cohort of Egyptian patients with refractory GERD symptoms strongly mandates the search for additional data concerning the indications for esophageal biopsy in this subset of patients. History of atopy may warrant suspicion of eosinophilic esophagitis in this subset of patients. VL - 2 IS - 2 ER -
Email: